Chemours 10-K/A: Disclosure Controls Were Not Effective From Dec 31, 2025 to Q3 2026
CC sits 27% above its 52-week low of $10.44.
Summary
Chemours' 10-K/A restores an omitted internal-control report and discloses that its disclosure controls and procedures were not effective from December 31, 2025 until Q3 2026. Financial statements and the auditor's unqualified ICFR opinion are unchanged.
Key Events · Corporate Governance and Compliance · CC
-
10-K/A Fixes Omitted ICFR Report
Amendment No. 1 to the FY2025 Form 10-K, originally filed February 24, 2026, adds Management's Report on Internal Control over Financial Reporting, which was inadvertently left out.
-
Disclosure Controls Deemed Not Effective
CEO and CFO concluded disclosure controls and procedures were not effective as of December 31, 2025 because of the administrative omission, reversing the original filing's conclusion.
-
Gap Lasted Into Third Quarter 2026
The ineffectiveness existed from December 31, 2025 until Q3 2026, when management added review procedures covering completeness of non-financial statement disclosures.
-
Financials and ICFR Opinion Unchanged
Management still concludes internal control over financial reporting was effective at December 31, 2025, and PwC's unqualified opinion was already in the original filing; no financial statements were amended.
Analysis · CC · Industrial Applications And Services
Chemours amended its FY2025 annual report to fix an administrative error — Management's Report on Internal Control over Financial Reporting was left out of the original February 24, 2026 filing — and in doing so reversed its controls conclusion. The CEO and CFO now say disclosure controls and procedures were not effective as of December 31, 2025, and that the ineffectiveness persisted until the third quarter of 2026, when extra review procedures were added. The underlying numbers are untouched: management still calls internal control over financial reporting effective, PwC's unqualified opinion stands, and no financial statements changed. That keeps this short of a restatement, but a first-time disclosure that controls failed for roughly three quarters lands on a company already carrying a $274M quarterly net loss, negative stockholders' equity, and $1.45 billion of environmental and litigation reserves — exactly the profile where disclosure-control gaps draw scrutiny.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CC was trading at $13.23 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $2B. The 52-week trading range was $10.44 to $28.67. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.